Drug Database
Back to search

Poland· PL-100201652

Nitrendypina Egis

A nitrendipine product containing nitrendipinum, registered in Poland by Egis Pharmaceuticals PLC. The same ATC class is registered in 6 of our 19 countries.

ATC C08CA08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNitrendypina EgisATCC08CA08REGISTER NO.PL-100201652PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nitrendipinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nitrendipine is registered in 6 of 19 countries.

Countries holding a registration under ATC C08CA08 (nitrendipine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search nitrendipine products by name

Nitrendipine · ATC C08CA08

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Polandprice
  • Spainprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nitrendipine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nitrendipine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • FR France$0.37
  • ES Spain$0.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Nitrendipinum
Manufacturer
Egis Pharmaceuticals PLC
Country
Poland (PL)
ATC code
C08CA08
ATC class
Nitrendipine
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

2 priced
  • gtin
    05909990694785
    60 szt.
    PLN 11.71
  • gtin
    05909990694778
    30 szt.
    PLN 6.35
  • gtin
    05909990277216
  • gtin
    05909990277223

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for nitrendipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nitrendipine against other medicinesHow interaction checks work

Nitrendipine · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Nitrendipine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nitrendipine products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Czechia · Lusopress, Nitrendipin Ratiopharm
  • Germany · Nitrendipin Abz, Nitrendipin Al
  • Estonia · Lusopress, Nitresan
  • France · Nitrendipine Viatris
  • Greece · Lisba, Nelconil
  • Italy · Lusopress
  • Lithuania · Lusopress, Nitresan
  • Latvia · Lusopress, Nitresan
  • Portugal · Hiperdipina
  • Slovakia · Lusopress, Nitresan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9c14e22-1647-4fc4-b5cc-e02523a692f5
GET /v1/drugs/b9c14e22-1647-4fc4-b5cc-e02523a692f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909990277216 ¦ Rp ¦ 7110\n30 tabl. (1 x 30)\n05909990277223 ¦ Rp ¦ 20804\n60 tabl. (2 x 30)\n05909990694778 ¦ Rp ¦ 49626\n30 tabl. (2 x 15)\n05909990694785 ¦ Rp ¦ 49627\n60 tabl. (4 x 15)",
  "substance": "Nitrendipinum 10 mg",
  "common_name": "Nitrendipinum",
  "pl_product_id": "100201652",
  "pozwolenie_nr": "02772",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about nitrendipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console